Compounds > 7-hydroxy-2-n,n-dipropylaminotetralin
Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Alloxan Diabetes

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Alloxan Diabetes in 2 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamei, J2
Saitoh, A1
Ohsawa, M1

Other Studies

2 other studies available for 7-hydroxy-2-n,n-dipropylaminotetralin and Alloxan Diabetes

ArticleYear
Modification of the effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes.
    Life sciences, 1996, Volume: 59, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Ex

1996
Effects of diabetes on methamphetamine-induced place preference in mice.
    European journal of pharmacology, 1996, Dec-30, Volume: 318, Issue:2-3

    Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Methamphetamine; M

1996